 |
|
 |
Our "Search and Develop" model has proven track record in attracting scores of our current principals. We serve as a relevant connection to the Southeast Asia market. To complement our core capabilities, our business development efforts concentrate on the following strategic aims:
Acquisition/In-licensing of Innovative Products with Strong Growth Potential
These could be approved products in other countries or drugs undergoing human Phase III trial.
Business Partnerships & Strategic Alliances with Pharmaceutical Players
Our experience with both MNCs and mid-size pharmaceutical companies adds value to future collaborations.
In this process, we actively seek out product candidates in several therapeutic arenas:
• Allergy & ENT
• Gastroenterology
• Obstetrics & Gynecology
• Ophthalmology
• Pediatrics
• Radiology
• Rheumatology |
|
|
|
|